Here's Why We Think Abcam (LON:ABC) Is Well Worth Watching

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it completely lacks a track record of revenue and profit. But as Warren Buffett has mused, 'If you've been playing poker for half an hour and you still don't know who the patsy is, you're the patsy.' When they buy such story stocks, investors are all too often the patsy.

If, on the other hand, you like companies that have revenue, and even earn profits, then you may well be interested in Abcam (LON:ABC). While profit is not necessarily a social good, it's easy to admire a business than can consistently produce it. While a well funded company may sustain losses for years, unless its owners have an endless appetite for subsidizing the customer, it will need to generate a profit eventually, or else breathe its last breath.

View our latest analysis for Abcam

Advertisement

Abcam's Earnings Per Share Are Growing.

The market is a voting machine in the short term, but a weighing machine in the long term, so share price follows earnings per share (EPS) eventually. Therefore, there are plenty of investors who like to buy shares in companies that are growing EPS. Abcam managed to grow EPS by 16% per year, over three years. That growth rate is fairly good, assuming the company can keep it up.

One way to double-check a company's growth is to look at how its revenue, and earnings before interest and tax (EBIT) margins are changing. The good news is that Abcam is growing revenues, and EBIT margins improved by 3.4 percentage points to 29%, over the last year. That's great to see, on both counts.

AIM:ABC Income Statement, August 26th 2019
AIM:ABC Income Statement, August 26th 2019

In investing, as in life, the future matters more than the past. So why not check out this free interactive visualization of Abcam's forecast profits?

Are Abcam Insiders Aligned With All Shareholders?

It makes me feel more secure owning shares in a company if insiders also own shares, thusly more closely aligning our interests. As a result, I'm encouraged by the fact that insiders own Abcam shares worth a considerable sum. Indeed, they have a glittering mountain of wealth invested in it, currently valued at UK£238m. This suggests to me that leadership will be very mindful of shareholders' interests when making decisions!

Should You Add Abcam To Your Watchlist?

One important encouraging feature of Abcam is that it is growing profits. Just as polish makes silverware pop, the high level of insider ownership enhances my enthusiasm for this growth. That combination appeals to me, for one. So yes, I do think the stock is worth keeping an eye on. Now, you could try to make up your mind on Abcam by focusing on just these factors, or you could also consider how its price-to-earnings ratio compares to other companies in its industry.

Of course, you can do well (sometimes) buying stocks that are not growing earnings and do not have insiders buying shares. But as a growth investor I always like to check out companies that do have those features. You can access a free list of them here.

Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

About AIM:ABC

Abcam

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery.

Excellent balance sheet and good value.

Advertisement

Weekly Picks

CE
Ceazar
CNXU logo
Ceazar on Conexeu Sciences ·

This small biotech is developing technology that could potentially change how tissue is rebuilt

Fair Value:US$25.3447.6% undervalued
32 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
HE
HedgeY
PWR logo
HedgeY on Quanta Services ·

The Picks-and-Shovels Leader of the Grid Supercycle

Fair Value:US$7101.1% undervalued
51 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
FU
KRMN logo
FundamentalFlow on Karman Holdings ·

KRMN — Karman Space & Defense: Down 58% from Peak, Is the Market Mispricing a Hypergrowth Defense Compounder?

Fair Value:US$105.652.3% undervalued
28 users have followed this narrative
2 users have commented on this narrative
13 users have liked this narrative
DO
Double_Bubbler
IES logo
Double_Bubbler on Invinity Energy Systems ·

Invinity Energy Systems: All About That BESS

Fair Value:UK£162.2% undervalued
38 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

RO
RockeTeller
AREC logo
RockeTeller on American Resources ·

American Resources, $263M Market Cap + 19% ReElement Stake, From Coal to Critical Minerals

Fair Value:US$557.0% undervalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HU
EPB logo
Hunter_Z on EPB Group Berhad ·

EPB: Strong Shareholder Backing, Continuous Insider Buying and Growth Opportunities Ahead

Fair Value:RM 0.548.0% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YO
MS
youwakeup on Harvest Strategy Enhanced High Income Shares ETF ·

MSTE: Turning Bitcoin Volatility Into Monthly Cash Flow

Fair Value:CA$11.7579.4% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7444.1% undervalued
68 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9639.0% undervalued
58 users have followed this narrative
9 users have commented on this narrative
17 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1928.5% undervalued
52 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative